focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,160.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 140.00 (3.365%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

10 Sep 2009 16:02

RNS Number : 8764Y
North Atlantic Smlr Co Inv Tst PLC
10 September 2009
 



North Atlantic Smaller Companies Investment Trust plc

Half Yearly Financial Report for the six months ended

31 July 2009

Objective of the company and financial highlights 

The objective of the Company is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean

31 July

31 January 

2009

2009

%

(unaudited)

(audited)

Change

Net asset value per 5p Ordinary Share*:

Basic

1,315p

1,204p

9.2

Diluted

1,029p

944p

9.0

Mid-market price of the 5p Ordinary Shares 

791.5p

618.5p

28.0

Discount to diluted net asset value*

23.1%

34.5%

Standard & Poor's 500 Composite Index**

590.8

568.0

4.0

Russell 2000 **

333.1

305.1

9.2

FTSE All-Share Index

2,353.5

2,078.9

13.2

US Dollar/Sterling exchange rate

1.6579

1.4417

15.0

* Including retained revenue for the period. ** Sterling adjusted.

 

Chief executive's review

I am pleased to report that during the six month period to 31 July 2009, the fully diluted net asset value of the Company rose by 9% outperforming the Sterling adjusted Standard and Poor's Composite Index which rose by 4%.

Net income for the period amounted to a loss of £105,000 (2008: profit £264,000) despite the successful recovery from HM Revenue & Customs of approximately £450,000 for VAT overpaid on investment management fees and certain other fees in the past, following the decision in the Fleming Claverhouse case. Consistent with long term policy, your Directors do not intend to pay a dividend. Although no shares or Convertible Unsecured Loan Stock ("CULS") were acquired for cancellation during the period, 100,000 CULS were acquired in early August.

Listed equities 

Smaller companies which had been heavily hit in the third quarter of 2008 achieved a major rally from the lows that were reached in March. In particular, Castle Support Services, RPC Group, Essenden and BBA performed well assisted by operating results which were generally better than market expectations. Oryx International Growth Fund also saw a notable increase in its net asset value. The principal disappointment was Communisis which, due to weaker than expected profitability, fell some 40% over the period.

The Company's only major new position was Celsis which performed in line with the market and for which the Company is participating in a recommended takeover following the end of the period.

The Company's cash balance increased during the period as the holdings in Filtronic, GNE and Fayrewood were liquidated and a number of the escrow payments from businesses sold in the past two years have been released.

Unlisted equities

The unquoted portfolio benefited from the successful takeover of GNE by Norcliffe Investments. GNE's assets have now been liquidated realising a profit to the Company in excess of £3 million.

Hampton Trust successfully sold an intellectual property asset which resulted in a write-up in the value of the investment and a return of capital in cash of some £5.6 million. Against this, it was necessary to write off in full the holding in Crendon Industrial.

Small investments were made in Valiant Holdings and approximately £2.8 million was invested in Orthoproducts to enable that company to make a small acquisition.

Outlook

The market's strong rally has continued into August and the Company continues to benefit from this. In addition, a number of the listed companies are in discussions which may lead to an offer for the business. However, some very significant problems remain meaning that any recovery in economic activity is likely to be muted. World economies in general are now dependant on unsustainable levels of government borrowing, unemployment continues to rise and consumer debt levels are too high. Bank stocks have led the advance in the stock market as they claw themselves back from oblivion. Despite Government assurances to the contrary, credit for business remains extremely tight and, when available, very expensive.

In these circumstances it is intended that the Company continue with its conservative approach to the markets over the balance of the fiscal year.

C H B MillsChief Executive

10 September 2009

 

Top ten investments

as at 31 July 2009

Fair

% of

Company

value £'000

net assets

Castle Support Services PLC

UK Quoted on AIM

19,840

10.2

Oryx International Growth Fund Limited*+

UK Listed

14,213

7.3

RPC Group PLC

UK Listed

11,150

5.7

Nationwide Accident Repair Services PLC

UK Quoted on AIM

8,500

4.4

BBA Aviation Group PLC

UK Listed

8,115

4.2

Hampton Trust Group

UK Unquoted

7,440

3.8

Trident Private Equity Fund II LP

Cayman Islands Unquoted

6,842

3.5

Asset Co Limited Preference Shares

UK Unquoted

6,500

3.3

Bionostics Holdings Limited Preference Shares

US Unquoted

6,102

3.1

US Treasury Bills

US Treasury Stock

6,030

3.1

94,732

48.6

* Incorporated in Guernsey

+ Oryx is accounted for in the Group accounts as an Associate under the equity method of accounting. The valuation shown above is the Group's share of Oryx's net assets. All other investments are valued at fair value.

 

Interim management report

 

Investment objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Material events

At the Annual General Meeting of the Company held on 30 June 2009, Mr Enrique Foster Gittes stepped down as Chairman after ten years in the role. Mr Gittes will remain on the Board as a Non-Executive Director. The Honourable Peregrine Moncreiffe, who re-joined the Board on 17 November 2008, became Chairman of the Company following the Annual General Meeting.

On 23 July 2009 there was a meeting of the holders of the Company's Convertible Unsecured Loan Stock 2013 ("CULS") at which an Extraordinary Resolution was passed authorising the purchase of the Company's own ordinary shares for cancellation. The Company is authorised to purchase its own shares, in line with Article 11 of the Company's Articles of Association. However, under the trust deed dated 26 November 1993 constituting the CULS, the Company also required the authorisation of the Stockholders in order to obtain the Buy Back Authority.

The Directors intend to exercise this authority only when, in the light of market conditions prevailing at the time and taking into account investment opportunities, appropriate gearing levels and the overall financial position, they believe that the effect of such purchases will be to increase the underlying value per Ordinary Share having regard to the interests of shareholders and loan stock holders generally.

Material transactions 

The Board does not consider that there were any material transactions during the period ended 31 July 2009.

Risk profile

The principal risks and uncertainties for the remaining six months of the year continue to be as described in the Annual Report for the year ended 31 January 2009 on pages 65-74. The principal risks arising from the Group's financial instruments are market price risk and foreign currency risk. The Directors review and agree policies with the Joint Manager, North Atlantic Value LLP, for managing these risks. The policies have remained substantially unchanged in the six months since the year end.

The Group does not have any significant exposure to credit risk arising from any one individual party. Credit risk is spread across a number of companies, each having an immaterial effect on the Group's cash flows, should a default occur.

To support its investment in unquoted companies, the Group may periodically agree to guarantee all or part of the borrowings of investee companies. Provision is made for any costs that may be incurred when the Directors consider it likely that the guarantee will crystallise.

The Group's exposure to market price risk comprises mainly movements in the value of the Group's investments. It should be noted that the prices of options tend to be more volatile than the prices of the underlying securities.

The functional and presentational currency of the Group is Sterling, and therefore, the Group's principal exposure to foreign currency risk comprises investments priced in other currencies, principally US Dollars.

The Group invests in equities and other investments that are readily realisable.

 

Related party transactions

These are listed in note 9 to the half yearly condensed financial statements.

 

CULS

The CULS were issued in units of 5p each. The units are redeemable at par on 31 May 2013, unless previously redeemed, purchased by the Company, or converted at the option of the holder.

During the period ended 31 July 2009, 28,679 (2008: 20,340) units of CULS were converted into Ordinary Shares of 5p each at the rate of one 5p Ordinary Share for every unit of 5p. The Company did not purchase any units of CULS for cancellation during the period under review (2008: 520,000).

The CULS units are convertible into Ordinary Shares of 5p each at a rate of one Ordinary Share for every 5p unit, one month after despatch of the audited accounts in each of the years 2009 to 2013 inclusive.

Interest is payable to holders of the CULS at a rate of 0.5p gross per 5p unit per annum on 31 January each year.

C H B MillsChief Executive

10 September 2009

 

 

Responsibility statement

The Directors confirm to the best of their knowledge that:

• The condensed set of financial statements contained within this half yearly financial report have been prepared in accordance with International Accounting Standard 34 'Interim Financial Reporting' as adopted by the European Union and gives a true and fair view of the assets, liabilities, financial position and profit of the Company; and

 The half yearly financial report includes a fair review of the information required by the FSA's Disclosure and Transparency Rule 4.2.7R being disclosure of important events that have occurred during the first six months of the financial year, their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the year; and

 The half yearly financial report includes a fair review of the information required by the FSA's Disclosure and Transparency Rule 4.2.8R being disclosure of related party transactions during the first six months of the financial year, how they have materially affected the financial position of the Company during the period and any changes therein.

The half yearly financial report was approved by the Board on 10 September 2009 and the above responsibility statement was signed on its behalf by:

C H B MillsChief Executive

Consolidated statement of comprehensive income

Six months ended

Six months ended

31 July

31 July

2009

2008

(unaudited)

(unaudited)

Revenue

Capital

Revenue

Capital

return

return

Total

return

return

Total

£'000

£'000

£'000

£'000

£'000

£'000

Investment income

1,058 

-

1,058 

2,200 

2,200 

Net gains/(losses) on investments at

fair value through profit or loss

-

14,070 

14,070 

-

(17,117)

(17,117)

Currency exchange gains/(losses)

-

225 

225 

-

(207)

(207)

total income

1,058 

14,295 

15,353 

2,200 

(17,324)

(15,124)

Expenses

Investment management

fee (note 2)*

(480)

(422)

(902)

(1,238)

(11)

(1,249)

Share based remuneration

-

-

-

(90)

-

(90)

Other expenses

(548)

-

(548)

(351)

-

(351)

Share of net return of associate

-

2,985 

2,985 

-

(2,063)

(2,063)

profit before finance costs and taxation

30 

16,858 

16,888 

521 

(19,398)

(18,877)

Finance costs

(133)

-

(133)

(257)

-

(257)

profit before taxation

(103)

16,858 

16,755 

264 

(19,398)

(19,134)

Taxation

(2)

-

(2)

-

-

-

profit for the period

(105)

16,858 

16,753 

264 

(19,398)

(19,134)

other comprehensive income

-

-

-

-

-

-

total comprehensive income for the period

(105)

16,858 

16,753 

264 

(19,398)

(19,134)

earnings per ordinary share (note 4)

Basic

113.22p

(129.46)p

Diluted

89.87p

(98.27)p

All of the profit/ (loss) for the period and the total comprehensive income for the period is attributable to the owners of the Company.

The total column of the statement is the Statement of Comprehensive Income of the Company prepared in accordance with IFRS. The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice issued by the Association of Investment Companies.

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.

* Net of VAT refund.

  consolidated statement of comprehensive income (continued)

Year ended

31 January

2009

(audited)

Revenue

Capital

return

return

Total

£'000

£'000

£'000

Investment income

4,285 

-

4,285 

Net gains/(losses) on investments  at fair value through profit or loss

-

(54,325)

(54,325)

Currency exchange gains/(losses)

-

7,042 

7,042 

total income

4,285 

(47,283)

(42,998)

Expenses

Investment management

fee (note 2)

(2,475)

(110)

(2,585)

Share based remuneration

(50)

-

(50)

Other expenses

(733)

-

(733)

Share of net return of associate

-

(7,677)

(7,677)

profit before finance costs

and taxation

1,027 

(55,070)

(54,043)

Finance costs

(487)

-

(487)

profit before taxation

540 

(55,070)

(54,530)

Taxation

(2)

-

(2)

profit for the year

538 

(55,070)

(54,532)

other comprehensive income

-

-

total comprehensive income

for the period

538 

(55,070)

(54,532)

earnings per ordinary share (note 4)

Basic

(368.77)p

Diluted

(284.47)p

All of the profit/ (loss) for the period and the total comprehensive income for the period is attributable to the owners of the Company.

The total column of the statement is the Statement of Comprehensive Income of the Company prepared in accordance with IFRS. The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice issued by the Association of Investment Companies.

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.

  Consolidated statement of changes in equity

Share

Share

Share

CULS

options

premium

Capital

Revenue

capital

reserve

reserve

account

reserve

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Six months ended 31 July 2009

(unaudited)

31 January 2009 

740 

29 

1,348 

629 

177,766 

(2,392)

178,120 

Total recognised income and expenses for the period 

-

-

-

-

16,858 

(105)

16,753 

Arising on conversion of CULS

-

-

-

-

-

31 July 2009

741 

29 

1,348 

629 

194,624 

(2,497)

194,874 

Year ended 31 January 2009

(audited)

31 January 2008

739 

34 

1,341 

629 

238,161 

(2,930)

237,974 

Total recognised income and expenses for the year 

-

-

-

-

(55,070)

538 

(54,532)

Premium paid on repurchase of CULS

-

-

-

-

(5,325)

-

(5,325)

Share Options expense

-

-

90 

-

-

-

90 

Exercise of Management Options

-

-

(83)

-

-

-

(83)

Arising on conversion of CULS

(5)

-

-

-

-

(4)

31 January 2009

740 

29 

1,348 

629 

177,766 

(2,392)

178,120 

Six months ended 31 July 2008

(unaudited)

31 January 2008

739 

34 

1,341 

629 

238,161 

(2,930)

237,974 

Total recognised income and expenses for the period 

-

-

-

-

(19,398)

264 

(19,134)

Premium paid on repurchase of CULS

-

(4)

-

-

(4,680)

-

(4,684)

Share Options expense

-

-

90 

-

-

-

90 

Arising on conversion of CULS

-

-

-

-

-

31 July 2008

740 

30 

1,431 

629 

214,083 

(2,666)

214,247 

Consolidated balance sheet 

31 July

31 January

31 July

2009

2009

2008

(unaudited)

(audited)

(unaudited)

£'000

£'000

£'000

non current assets

Investments at fair value through profit or loss 

153,294 

147,505 

188,574 

Investments accounted for using the equity method

14,213 

11,228 

16,842 

167,507 

158,733 

205,416 

current assets

Investments held for trading in Subsidiary Companies

367 

-

Trade and other receivables

3,582 

3,989 

4,386 

Cash and cash equivalents

35,604 

25,514 

13,533 

39,553 

29,503 

17,920 

total assets

207,060 

188,236 

223,336 

current liabilities

Bank loans and overdrafts

(7,358)

(7,874)

(7,285)

Investments held for trading - derivatives

(533)

(838)

(122)

Trade and other payables

(4,132)

(1,240)

(1,513)

(12,023)

(9,952)

(8,920)

total assets less current liabilities

195,037 

178,284 

214,416 

non current liabilities

CULS

(163)

(164)

(169)

(163)

(164)

(169)

total liabilities

(12,186)

(10,116)

(9,089)

net assets

194,874 

178,120 

214,247 

represented by:

Share capital

741 

740 

740 

Equity component of CULS

29 

29 

30 

Share options reserve

1,348 

1,348 

1,431 

Share premium account

629 

629 

629 

Capital reserve

194,624 

177,766 

214,083 

Revenue reserve

(2,497)

(2,392)

(2,666)

equity attributable to equity holders

of the parent

194,874 

178,120 

214,247 

net asset value per ordinary share (note 5):

Basic

1,315p

1,204p

1,448p

Diluted

1,029p

944p

1,121p

 

Consolidated cash flow statement

Six months

Six months

Year ended

ended 31 July

ended 31 July

31 January

2009

2008

2009

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

cash flows from operating activities 

Investment income received

1,133 

1,892 

3,202 

Bank deposit interest received

17 

161 

376 

Other income

29 

78 

100 

Sale of investments by dealing Subsidiary 

(341)

-

-

Investment Manager's fees paid

(1,219)

(2,486)

(3,626)

Other cash payments

(53)

(378)

(466)

cash expended from operations

(434)

(733)

(414)

Bank interest paid

(188)

(280)

(457)

CULS interest paid

-

-

(19)

net cash outflow from operating activities

(622)

(1,013)

(890)

cash flows from investing activities

Purchases of investments

(71,870)

(85,219)

(153,593)

Sales of investments

82,218 

97,803 

172,624 

net cash inflow from investing activities

10,348 

12,584 

19,031 

cash flows from financing activities

Repayment of fixed term borrowings

(282)

(3,506)

(2,777)

Increase in fixed term borrowings

-

1,108 

-

Repurchase of CULS for cancellation

-

(3,995)

(5,357)

Management options exercised

-

-

(83)

net cash outflow from financing activities

(282)

(6,393)

(8,217)

increase in cash and cash equivalents

for the period

9,444 

5,178 

9,924 

cash and cash equivalents at the start of

the period

25,514 

8,504 

8,504 

Revaluation of foreign currency balances

646 

(149)

7,086 

cash and cash equivalents at the end of

the period

35,604 

13,533 

25,514 

 

Notes

1. Basis of preparation

North Atlantic Smaller Companies Investment Trust plc ("NASCIT") is a Company incorporated and registered in England and Wales under the Companies Acts 1948 to 1967.

The condensed consolidated interim financial information for the six months ended 31 July 2009 have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all financial information required for full annual financial statements. They have been prepared using the accounting policies adopted in the audited financial statements for the year ended 31 January 2009. Those financial statements were prepared in accordance with International Financial Reporting Standards. In addition the Company has adopted the Association of Investment Companies Statement of Recommended Practice regarding the Financial Statements of Investment Trust Companies and Venture Capital Trusts issued January 2009. 

The condensed consolidated interim financial information consolidate the financial statements of the Company and its wholly owned Subsidiary, Consolidated Venture Finance Limited, for the six months ended 31 July 2009.

2. Investment management and performance fees

A Performance Fee is only payable if the investment portfolio outperforms the Sterling adjusted Standard & Poor's 500 Composite Index at the end of each financial year and is limited to a maximum payment of 0.5% of Shareholders' Funds.

In accordance with the Statement of Recommended Practice ("SORP") for investment trust companies, an amount is included in these financial statements for the Performance Fee that could be payable based on investment performance to 31 July 2009.

At that date, a Performance Fee of £422,000, has been accrued for in the accounts (31 July 2008: £11,000 including irrecoverable VAT; 31 January 2009: £110,000) and is allocated 100% to capital.

3. Taxation

The Company has an effective tax rate of 0%. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income and thus there is no charge for corporation tax.

4. Earnings per ordinary share

Revenue

Capital

*Net

Per

*Net

Per

return

Ordinary

Share

return

Ordinary

Share

£'000

Shares

pence

£'000

Shares

pence

Six months ended 31 July 2009

(unaudited)

Basic return per Share

(105)

14,796,974 

(0.71)

16,858 

14,796,974 

113.93 

Options conversion**

-

-

-

-

CULS***

19 

3,865,078 

-

3,865,078 

Diluted return per Share

(86)

18,662,052 

(0.46)

16,858 

18,662,052 

90.33 

Six months ended 31 July 2008

(unaudited)

Basic return per Share

264 

14,779,454 

1.79 

(19,398)

14,779,454 

(131.25)

Options conversion**

-

268,431 

-

268,431 

CULS***

22 

4,401,141 

-

4,401,141 

Diluted return per Share

286 

19,449,026 

1.47 

(19,398)

19,449,026 

(99.74)

Year ended 31 January 2009

(audited)

Basic return per Share

538 

14,787,546 

3.64 

(55,070)

14,787,546 

(372.41)

Options conversion**

-

201,023 

-

201,023 

CULS***

21 

4,173,720 

-

4,173,720 

Diluted return per Share

559 

19,162,289 

2.92 

(55,070)

19,162,289 

(287.39)

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

* Net return on ordinary activities attributable to Ordinary Shareholders.

** Excess of the total number of potential Shares on option conversion over the number that could be issued at average market price, as calculated in accordance with IAS 33: Earnings per Share.

*** CULS assumed converted as average share price during the period was greater than the conversion price.

 

4. Earnings per ordinary share (continued)

Total

*Net

Per

return

Ordinary

Share

£'000

Shares

pence

Six months ended 31 July 2009

(unaudited)

Basic return per Share

16,753 

14,796,974 

113.22 

Options conversion**

-

-

CULS***

19 

3,865,078 

Diluted return per Share

16,772 

18,662,052 

89.87 

Six months ended 31 July 2008

(unaudited)

Basic return per Share

(19,134)

14,779,454 

(129.46)

Options conversion**

-

268,431 

CULS***

22 

4,401,141 

Diluted return per Share

(19,112)

19,449,026 

(98.27)

Year ended 31 January 2009

(audited)

Basic return per Share

(54,532)

14,787,546 

(368.77)

Options conversion**

-

201,023 

CULS***

21 

4,173,720 

Diluted return per Share

(54,511)

19,162,289 

(284.47)

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

* Net return on ordinary activities attributable to Ordinary Shareholders.

** Excess of the total number of potential Shares on option conversion over the number that could be issued at average market price, as calculated in accordance with IAS 33: Earnings per Share.

*** CULS assumed converted as average share price during the period was greater than the conversion price.

5. Net asset value per ordinary share

The basic net asset value per Ordinary Share is based on net assets of £194,874,000 (31 January 2009: £178,120,000; 31 July 2008: £214,247,000) and on 14,824,227 Ordinary Shares (31 January 2009: 14,795,548; 31 July 2008: 14,795,548) being the number of Ordinary Shares in issue at the period end.

The diluted net asset value per Ordinary Share is calculated on the assumption that the outstanding 2013 CULS are fully converted at par and that all 1,017,500 (31 January 2009: 1,017,500; 31 July 2008: 1,030,000) Share Options in-the-money were exercised at the prevailing exercise prices, giving a total of 19,679,552 issued Ordinary Shares (31 January 2009: 19,679,552; 31 July 2008: 19,802,052).

6. Debenture loan - convertible unsecured loan stock ('CULS') 2013

On 22 July 2009 28,679 CULS units were converted into 28,679 Ordinary shares of 5p each at a rate of one 5p Ordinary share for every unit of 5p.

At 31 July 2009 3,837,825 CULS units remained outstanding.

7. Bank loans

The Company's multi-currency loan Revolving Credit Facility of up to £9 million was due to expire on 31 July 2009. During the period the Company negotiated an extension on this facility to 31 July 2010.

During the period the Company repaid 300,000. The Company currently has 7.3 million Euros and 2 million Canadian Dollars drawn down which are due for repayment within the next six months.

8. Reconciliation of total return from ordinary activities before finance costs and taxation to cash expended from operations

Six months

Six months

Year ended

ended 31 July

ended 31 July

31 January

2009

2008

2009

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Profit/(loss) before finance costs and taxation*

16,888 

(18,877)

(54,043)

(Gains)losses on investments

(14,295)

17,324 

47,283 

Share based remuneration

-

90 

90 

Share of net return of associate

(2,985)

2,063 

7,677 

Dividends and interest reinvested

(297)

(433)

(804)

Decrease in debtors and accrued income

157 

206 

636 

Changes relating to investments of dealing Subsidiaries

(280)

305 

126 

Increase/(decrease) in creditors and accruals

380 

(1,411)

(1,377)

Tax on investment income

(2)

-

(2)

cash expended from operations

(434)

(733)

(414)

* including share of net return of associate

 

9. Related party transactions

The Joint Manager, North Atlantic Value LLP, is regarded as a related party of the Company. The amounts payable to the Joint Manager and Growth Financial Services Limited ("GFS") in respect of investment management for the six months to 31 July 2009 are as follows:

Six months

Six months

Year ended

ended 31 July

ended 31 July

31 January

2009

2008

2009

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Annual fee

938 

1,238 

2,475 

VAT reclaimed on Investment Management fees

(458)

-

-

Performance fee

422 

10 

110 

Irrecoverable VAT thereon

-

-

902 

1,249 

2,585 

In addition to the management fees disclosed above, North Atlantic Value LLP is also paid:

- an activity fee of £225 per transaction as reimbursement of custodian and related transaction costs incurred on the Company's behalf.

- an investment management related fee of £100,000 per annum.

10. Financial information

The annual financial information contained in this Half Yearly Report does not constitute full Statutory accounts as defined in Section 240 of the Companies Act 1985. The financial information for the periods ended 31 July 2009 and 31 July 2008 is not a financial year and has not been audited. The statutory accounts for the financial year ended 31 January 2009 have been delivered to the Registrar of Companies and received an Audit Report which was unqualified, did not include a reference to any matters to which the Auditors drew attention by way of emphasis without qualifying the Report and did not contain statements under Section 237(2) and (3) of the Companies Act 1985.

Shareholder information

 

Financial calendar

Preliminary resultsMay Annual ReportMay Annual General MeetingJune Half Yearly figures announcedSeptember Half Yearly Report postedSeptember

 

Share price

The Company's mid-market share price and CULS price are quoted daily in the Financial Times appearing under "Investment Companies".

They also appear on:

Reuters: Convertible Loan Stock NASp.L Bloomberg: NAS. LN SEAQ Ordinary Shares: NAS Trustnet: www.trustnet.ltd.uk

 

Net asset value

The latest net asset value of the Company can be found on the North Atlantic Value LLP website: www.navalue.co.uk

 

Share dealing

Investors wishing to purchase more Ordinary Shares or dispose of all or part of their holding may do so through a stockbroker. Many banks also offer this service.

The Company's registrars are Capita Registrars. In the event of any queries regarding your holding of shares, please contact the registrars on: 0870 458 4577, or by email on ssd@capitaregistrars.com

Changes of name or address must be notified to the registrars in writing at:

Capita Registrars The Registry34 Beckenham RoadBeckenhamKent BR3 4TU

Directors

The Hon. P D Moncreiffe (Chairman) C H B Mills (Chief Executive) E F Gittes K Siem C L A Irby O R Grace

Joint Manager

North Atlantic Value LLP (Authorised and regulated by the Financial Services Authority)

Ground Floor Ryder Court 14 Ryder StreetLondon SW1Y 6QB Telephone: 020 7747 5678

Financial Adviser and Stockbroker

Arbuthnot Securities Limited Arbuthnot House20 Ropemaker StreetLondon EC2Y 9AR

Company Secretary and Registered Office

J O Hambro Capital Management Limited Ground Floor Ryder Court 14 Ryder StreetLondon SW1Y 6QB Telephone: 020 7747 5681

Registrars

Capita Registrars The Registry34 Beckenham RoadBeckenhamKent BR3 4TU

Auditors

Grant Thornton UK LLP30 Finsbury SquareLondon EC2P 2YU

Bankers

Allied Irish Banks, p.l.c. St Helen's 1 UndershaftLondon EC3A 8AB

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR KGGMLDGNGLZM
Date   Source Headline
16th May 20242:46 pmRNSNet Asset Value(s)
14th May 202412:46 pmRNSTransaction in Own Shares
10th May 20247:00 amRNSFinal Results
17th Apr 202410:52 amRNSNet Asset Value(s)
12th Apr 20243:48 pmRNSHolding(s) in Company
8th Apr 20249:42 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202412:45 pmRNSTransaction in Own Shares - Replacement
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20243:55 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 202411:07 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSDividend Declaration
15th Feb 20247:00 amRNSNet Asset Value(s)
8th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20249:14 amRNSNew Investment: Crest Foods
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
17th Jan 20243:32 pmRNSNet Asset Value(s)
27th Dec 20237:00 amRNSDirector Declaration
19th Dec 20237:00 amRNSNet Asset Value(s)
6th Dec 20237:41 amRNSInvestment Update: Ten Entertainment Group Plc
16th Nov 202312:44 pmRNSNet Asset Value(s)
30th Oct 20232:30 pmRNSTransaction in Own Shares
23rd Oct 20232:10 pmRNSTransaction in Own Shares
16th Oct 202312:19 pmRNSNet Asset Value(s)
12th Oct 20238:43 amRNSReplacement: Private Equity Investment Disposal
12th Oct 20237:00 amRNSPrivate Equity investment disposal
9th Oct 20233:02 pmRNSTransaction in Own Shares
15th Sep 20237:00 amRNSHalf-year Report
14th Sep 20231:43 pmRNSNet Asset Value(s)
31st Aug 20234:40 pmRNSCompany Secretary Change
29th Aug 20233:46 pmRNSTransaction in Own Shares - Replacement
29th Aug 20232:49 pmRNSTransaction in Own Shares
21st Aug 20233:07 pmRNSTransaction in Own Shares
16th Aug 20234:15 pmRNSTransaction in Own Shares
15th Aug 202310:03 amRNSNet Asset Value(s)
14th Aug 20232:09 pmRNSTransaction in Own Shares
8th Aug 20234:30 pmRNSTransaction in Own Shares
7th Aug 20234:28 pmRNSTransaction in Own Shares
25th Jul 202312:52 pmRNSNanoco Group Plc
18th Jul 20233:23 pmRNSNet Asset Value(s)
17th Jul 202312:41 pmRNSPortfolio Update
10th Jul 20239:39 amRNSTransaction in Own Shares
3rd Jul 202310:14 amRNSTransaction in Own Shares
30th Jun 202312:17 pmRNSDirector/PDMR Shareholding
26th Jun 202310:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.